Chemokine CXCL-1: Activity in the vitreous during proliferative vitreoretinopathy

7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The aim of this study was to investigate CXCL-1 chemokine levels in the vitreous during rhegmatogenous retinal detachment (RRD) with and without proliferative vitreoretinopathy (PVR) and identify possible correlations with clinical parameters (extent and duration or RRD and PVR grade). Vitreous samples from patients with primary RRD with or without PVR were collected and assayed using a double antibody enzyme-linked immunosorbent assay (ELISA). Eleven vitreous samples from organ donors were employed as a control group. CXCL-1 levels were measured in 35 vitreous samples from 35 RRD patients. Mean CXCL-1 levels (64·82±6·47 pg/ml) were significantly higher (P = 0·048) compared to controls. There was a significant positive correlation between CXCL-1 levels and the extent of the detachment (r=0·794, P = 0·006). Peak CXCL-1 levels coincided with 3+ quadrant RRD, an interim of 29-60 days' duration and PVR grade B. Increased CXCL-1 levels may be indicative of mild inflammation in the detached retina and the adjacent vitreous. The results of the present study may provide novel insight into the complex interactions taking place during the early and late stages of RRD complicated by PVR.

Cite

CITATION STYLE

APA

Symeonidis, C., Androudi, S., Georgalas, I., Tzamalis, A., Chalvatzis, N., Rotsos, T., … Dimitrakos, S. A. (2015). Chemokine CXCL-1: Activity in the vitreous during proliferative vitreoretinopathy. Clinical and Experimental Immunology, 181(2), 338–342. https://doi.org/10.1111/cei.12627

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free